The June 8 edition of The New England Journal of Medicine includes “New FDA Regulation to Improve Safety Reporting in Clinical Trials.” Read here.
New FDA regulation for improving safety reporting in clinical trials discussed in The New England Journal of Medicine.
*Online Bonus Content: This has not been peer reviewed. The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal.